INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for scleroderma patients with scarred lungs
Disease control Recruiting nowThis study aims to test several new investigational drugs to see if they can slow or stop the progression of lung scarring in people with scleroderma. It will enroll 400 adults who have had scleroderma symptoms for 7 years or less and have evidence of lung involvement. Participan…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Phase: PHASE2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Scientists hunt for clues in blood and skin to unlock scleroderma mysteries
Knowledge-focused Recruiting nowThis study aims to discover what causes systemic sclerosis (scleroderma) and find markers that can predict how the disease will progress or respond to treatment. Researchers will collect and analyze blood, skin, and DNA samples from 150 patients in Sweden. The goal is to identify…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO SYSTEMIC DISEASE
Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC